Search Within

Martin Stuart Tallman

  1. "Survivorship Research"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (13)
  3. Research Letter (2)
Groups
  1. Adult Leukemia (34)
  2. Center for Hematologic Malignancies (34)
  3. Department of Medicine (34)
  4. Hematologic Malignancies, Division of (34)
  5. Survivorship Research (34)
  6. Biostatistics Service (24)

More Groups

People
  1. Sean Devlin (21)
  2. Sergio Giralt (18)
  3. Ross Levine (17)
  4. Miguel-Angel Perales (14)
  5. Boglarka Gyurkocza (13)
  6. Brian Shaffer (13)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (4)
  4. 2020 (5)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Blood (12)
  2. Biology of Blood and Marrow Transplantation (4)
  3. American Journal of Hematology (3)
  4. Cancer Research (2)
  5. Journal of Clinical Oncology (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. Elsevier Inc. (6)
  3. John Wiley & Sons, Inc. (3)
  4. American Association for Cancer Research (2)
  5. American Society of Clinical Oncology (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
    Journal Article

    Taylor, J.; Donoghue, M. T. A.; Ho, C.; Petrova-Drus, K.; Al-Ahmadie, H. A.; Funt, S. A.; Zhang, Y.; Aypar, U.; Rao, P.; Chavan, S. S.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
    Journal Article

    Coombs, C. C.; Zehir, A.; Devlin, S. M.; Kishtagari, A.; Syed, A.; Jonsson, P.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; more...
    Cell Stem Cell (2017)

    Fulltext@MSK | Save